Immunocore Holdings plc Annual Cost of Revenue in USD from 2021 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Immunocore Holdings plc quarterly/annual Cost of Revenue history and growth rate from 2021 to 2023.
  • Immunocore Holdings plc Cost of Revenue for the quarter ending June 30, 2024 was $1.71M, a 393% increase year-over-year.
  • Immunocore Holdings plc annual Cost of Revenue for 2023 was $1.04M, a 4.78% decline from 2022.
  • Immunocore Holdings plc annual Cost of Revenue for 2022 was $1.09M.
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.04M -$52K -4.78% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $1.09M +$1.09M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $0 Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.